课题基金 / 基金详情

KILLER CELL SURFACE ANTIGENS--BIOCHEMISTRY AND FUNCTION

KILLER CELL SURFACE ANTIGENS--BIOCHEMISTRY AND FUNCTION
杀伤细胞表面抗原——生物化学和功能
批准号:
3174706
负责人:
ROBERT E HALL
金额:
$16.28万
依托单位国家:
美国
项目类别:
财政年份:
1987
资助国家:
美国
项目状态:
已结题
起止时间:
1987-08-01 至 1991-09-30

项目摘要

项目成果

ROBERT E HALL的其他基金

相关文献

中文摘要
翻译
自然杀伤(NK)细胞、细胞毒性T淋巴细胞(CTL),以及 单核吞噬细胞(MP)代表了三个主要的系统, 宿主对肿瘤的防御 我们的实验室积极参与 在细胞表面事件的分子解剖中, 这些细胞介导的细胞毒性反应,通过使用 单克隆抗体作为结构和功能的探针。 在这 项目,我们建议继续研究 淋巴细胞功能相关抗原1(LFA-1) 细胞毒性细胞表面糖蛋白异二聚体家族, 特别强调NK系统和一个密切相关的 效应细胞,巨噬细胞因子(IL-2)激活的杀伤细胞。 我们的实验室目前正在探索以下假设, 细胞毒性系统:(1)LFA-1家族细胞表面密度 成员在细胞介导的细胞毒性的表达中是重要的 在这些系统中;(2)LFA-1有助于与非依从性相关的 NK系统中的功能,可能在后期步骤中发挥作用 在细胞溶解机制中,或在更全面的调节中, 细胞过程(例如,跨膜信号传导事件);和(3) IL-2在调节细胞溶解活性中一个重要作用 是增强LFA-1的表达, 机制等 在这一竞争延续申请中,我们 我提出了一系列的实验,旨在进一步测试这些 通过对结构、功能 表达和生物合成这个重要的表面家族 分子,以及尝试分离和鉴定 NK系统中LFA-1的假定靶细胞配体。 这样 我们将继续追求更好的长期目标, 在分子水平上理解细胞介导的宿主防御 对抗肿瘤。
英文摘要
Natural killer (NK) cells, cytotoxic T-lymphocytes (CTL's), and mononuclear phagocytes (MP) represent three major systems of host defense against tumors. Our laboratory is actively involved in the molecular dissection of cell-surface events important in the cytotoxic response mediated by these cells, through the use of monoclonal antibodies as probes of structure and function. In this project, we propose to continue our studies examining the role of the Lymphocyte Function-Associated Antigen-One (LFA-1) heterodimeric family of surface glycoproteins on cytotoxic cells, with special emphasis on the NK system and a closely-related effector cell, Lymphokine (IL-2)-Activated Killer Cells. Our laboratory is currently exploring the following hypotheses in cytotoxic systems: (1) that cell surface density of LFA-1 family members is important in expression of cell-mediated cytotoxicity in these systems; (2) that LFA-1 subserves non-adherence related function(s) in the NK system, possibly playing a role in a late step in the cytolytic mechanism or in more global regulation of cellular processes (e.g., transmembrane signalling events); and (3) that one important effect of IL-2 in modulating cytolytic activity is in enhancing expression of LFA-1, through as yet unknown mechanisms. In this Competing Continuation Application, we propose a series of experiments designed to further test these hypotheses through detailed study of the structure, function, expression, and biosynthesis of this important family of surface molecules, as well as proposals to attempt to isolate and identify the putative target cell ligand for LFA-1 in the NK system. In so doing, we will continue to pursue our long-term goal of better understanding, at the molecular level, cell-mediated host defense against tumors.
期刊论文(12)
专著(0)
科研奖励(0)
会议论文
Differentiation-inducing cytokine P48 exists in a membrane-associated form.
分化诱导细胞因子 P48 以膜相关形式存在。
DOI: --
发表时间: 1991
期刊: Journal of immunology (Baltimore, Md. : 1950)
影响因子: --
作者: [Kostyal,DA, Beezhold,DH, Hall,RE]
通讯作者: Hall,RE
Resistance to natural killer cell-mediated cytolysis by a pleiotropic drug-resistant human erythroleukemia (K562-R) cell line.
多效耐药人红白血病 (K562-R) 细胞系对自然杀伤细胞介导的细胞溶解的抵抗。
DOI: --
发表时间: 1986
期刊: Cancer research
影响因子: 11.2
作者: [Yanovich,S, Hall,RE, Weinert,C]
通讯作者: Weinert,C
Interleukin-2 modulates the expression of lymphocyte function-associated antigen-one (LFA-1) and p150,95 during the generation of lymphokine-activated killer (LAK) cells.
Interleukin-2 在淋巴因子激活杀伤 (LAK) 细胞生成过程中调节淋巴细胞功能相关抗原一 (LFA-1) 和 p150,95 的表达。
DOI: --
发表时间: 1989
期刊: Immunology
影响因子: 6.4
作者: [Grant,AJ, Merchant,RE, Hall,RE]
通讯作者: Hall,RE
Transient inhibition of DNA synthesis by 5-fluorodeoxyuridine leads to overexpression of dihydrofolate reductase with increased frequency of methotrexate resistance.
5-氟脱氧尿苷短暂抑制 DNA 合成会导致二氢叶酸还原酶过度表达,从而增加甲氨蝶呤耐药频率。
DOI: --
发表时间: 1988
期刊: The Journal of biological chemistry
影响因子: --
作者: [Schuetz,JD, Gorse,KM, Goldman,ID, Westin,EH]
通讯作者: Westin,EH
共 11 条
    CYTOKINE INDUCTION BY A 48 KD MYCOPLASMA GENE PRODUCT
    CYTOKINE INDUCTION BY A 48 KD MYCOPLASMA GENE PRODUCT
    CYTOKINE INDUCTION BY A 48 KD MYCOPLASMA GENE PRODUCT
    CYTOKINE INDUCTION BY A 48 KD MYCOPLASMA GENE PRODUCT
    • 批准号:
      6555584
    • 项目类别:
    • 资助金额:
      $6.85万
    • 财政年份:
      1997
    • 负责人:
      ROBERT E HALL
    • 依托单位: